Geri Dön

Diabetes Mellituslu hastalarda plazma, lokosit ve eritrosit içi çinko, bakır ve magnezyum düzeyleri

Başlık çevirisi mevcut değil.

  1. Tez No: 29373
  2. Yazar: TEMİR ALİ DEMİR
  3. Danışmanlar: DOÇ. DR. EKİN ÖNDER
  4. Tez Türü: Doktora
  5. Konular: Biyokimya, Biochemistry
  6. Anahtar Kelimeler: Belirtilmemiş.
  7. Yıl: 1993
  8. Dil: Türkçe
  9. Üniversite: Anadolu Üniversitesi
  10. Enstitü: Fen Bilimleri Enstitüsü
  11. Ana Bilim Dalı: Kimya Ana Bilim Dalı
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: 72

Özet

vi SUMMARY We determined zinc, copper and magnesium levels in plasma from 39 patients with Type II Diabetes Mellitus (DM) and 50 healthy men by using Atomic Absorbtion Spectrophotometer. The concentrations of zinc, copper and magnesium in leucocytes and erythrocytes have also been measured after preparation as described by using modified Boyum's method. The mean plasma levels in controls are; Zn : X = 990 ± 162 \ig/l, Cu : X = 817 ± 134 jj.g/1, Mg : X = 21.24 ± 1.02 mg/1. The mean erythrocytes levels in controls are; Zn : X = 14.92 ± 2.85 ^ig/1010 cells, Cu : X = 0.933 ± 0.13 Hg/1010 cells, Mg : X = 53.88 ± 6.4 |ig/1010 cells. The mean leucocytes levels in controls are; Zn : X = 87.46 + 33 jig/10 10 cells, Cu : X = 16.14 ± 7.1 ng/1010 cells, Mg : X = 397 ± 107 ng/1010 cells. The mean results of plasma in Type II Diabetes Mellitus patients are;vü Zn : X = 1072 ± 147 ^ıg/1, Cu : X = 1129 ± 109 ng/1, Mg : X = 20.346 ± 1.12 mg/1. The mean results of erythrocytes in Type II Diabetes Mellitus patients are; Zn : X = 14.96 ±4.1 ^ig/1010 cells, Cu : X = 0.539 ± 0.12 iig/1010 cells, Mg : X = 42.67 ± 5.4 ^ig/1010 cells. The mean results of leucocytes in Type II Diabetes Mellitus patients are; Zn : X = 84.05 ± 33 ng/1010 cells, Cu : X = 12.36 ± 5.6 |ig/1010 cells, Mg : X = 352 ± 64 ng/1010 cells. By the statistical evaluation, zinc and copper concentrations are significantly higher (p>0.01 and p>0.0005 respectively) but magnesium concentrations are significantly lower (p>0.0005) and in erythrocytes zinc concentrations are insignificantly higher (p>0.4) but copper and magnesium concentrations are significantly lower (p>0.0005) and finally in leucocytes zinc concentrations are insignificantly lower (p

Özet (Çeviri)

vi SUMMARY We determined zinc, copper and magnesium levels in plasma from 39 patients with Type II Diabetes Mellitus (DM) and 50 healthy men by using Atomic Absorbtion Spectrophotometer. The concentrations of zinc, copper and magnesium in leucocytes and erythrocytes have also been measured after preparation as described by using modified Boyum's method. The mean plasma levels in controls are; Zn : X = 990 ± 162 \ig/l, Cu : X = 817 ± 134 jj.g/1, Mg : X = 21.24 ± 1.02 mg/1. The mean erythrocytes levels in controls are; Zn : X = 14.92 ± 2.85 ^ig/1010 cells, Cu : X = 0.933 ± 0.13 Hg/1010 cells, Mg : X = 53.88 ± 6.4 |ig/1010 cells. The mean leucocytes levels in controls are; Zn : X = 87.46 + 33 jig/10 10 cells, Cu : X = 16.14 ± 7.1 ng/1010 cells, Mg : X = 397 ± 107 ng/1010 cells. The mean results of plasma in Type II Diabetes Mellitus patients are;vü Zn : X = 1072 ± 147 ^ıg/1, Cu : X = 1129 ± 109 ng/1, Mg : X = 20.346 ± 1.12 mg/1. The mean results of erythrocytes in Type II Diabetes Mellitus patients are; Zn : X = 14.96 ±4.1 ^ig/1010 cells, Cu : X = 0.539 ± 0.12 iig/1010 cells, Mg : X = 42.67 ± 5.4 ^ig/1010 cells. The mean results of leucocytes in Type II Diabetes Mellitus patients are; Zn : X = 84.05 ± 33 ng/1010 cells, Cu : X = 12.36 ± 5.6 |ig/1010 cells, Mg : X = 352 ± 64 ng/1010 cells. By the statistical evaluation, zinc and copper concentrations are significantly higher (p>0.01 and p>0.0005 respectively) but magnesium concentrations are significantly lower (p>0.0005) and in erythrocytes zinc concentrations are insignificantly higher (p>0.4) but copper and magnesium concentrations are significantly lower (p>0.0005) and finally in leucocytes zinc concentrations are insignificantly lower (p

Benzer Tezler

  1. Nikotinamidin kötü kontrollü tip 2 diyabetik olgularda nötrofil fagositoz ve oksidatif burst aktivitesine etkileri

    The effect of nicotinamide on neutrophil phagocytosis and oxidative burst activity in poorly controlled type 2 diabetic patients

    ZEYNEP OŞAR

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2005

    Endokrinoloji ve Metabolizma Hastalıklarıİstanbul Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    PROF.DR. HASAN İLKOVA

  2. Diabetes mellituslu hastalarda eritrosit-plazma lipid peroksidasyonunun hemoreolojik parametrelerle ilişkisinin incelenmesi

    Investigation of relationship between erythrocyte-plasma lipid peroxidation and hemorheologic parameters in patients with diabetes mellitus

    MELTEM ERCAN

    Doktora

    Türkçe

    Türkçe

    1997

    Biyofizikİstanbul Üniversitesi

    Biyofizik Ana Bilim Dalı

    PROF.DR. SİNAN ÖNEN

  3. Diyabet tanısı olan ve olmayan hastaların mean platelet volum MPV) açısından değerlendirilmesi

    Evaluation of mean platelet volume (MPV) for diabetic and non diabetic patients

    BERKER ŞEKER

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2017

    Aile Hekimliğiİzmir Katip Çelebi Üniversitesi

    Aile Hekimliği Ana Bilim Dalı

    YRD. DOÇ. GÜLSEREN PAMUK

  4. Akut böbrek hasarında p-cresyl sülfat sülfat ve indoxyl sülfat düzeylerinin tedavi öncesi ve sonrası değerlendirilmesi

    In acute renal failure evalotion of p-cresyl sülfat sulfate and indoxyl sulfate levels before and after treatment

    PERİHAN GEYİK

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2021

    İç HastalıklarıDüzce Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    PROF. DR. TANSU SAV